Effect of gastrointestinal manifestations on quality of life in 87 consecutive patients with systemic sclerosis

Journal of Rheumatology

Volumn 39, Issue 5, 2012, Pages 992-996

  Omair, Mohammed A ^a   Lee, Peter ^a  

^a UNIVERSITY OF TORONTO   (Canada)

Author keywords

Gastrointestinal tract; Quality of life; Systemic sclerosis

Indexed keywords

CALCIUM CHANNEL BLOCKING AGENT;

ADULT; ARTICLE; CLINICAL FEATURE; CONSTIPATION; CONTROLLED STUDY; DIARRHEA; DISEASE CLASSIFICATION; DISEASE DURATION; FECES INCONTINENCE; FEMALE; GASTROESOPHAGEAL REFLUX; GASTROINTESTINAL SYMPTOM; HUMAN; INTESTINE DISTENSION; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSPECTIVE STUDY; QUALITY OF LIFE; QUESTIONNAIRE; RHEUMATIC DISEASE; SOCIAL ASPECT; SYSTEMIC SCLEROSIS; WELLBEING;

FEMALE; GASTROINTESTINAL DISEASES; HUMANS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; QUALITY OF HEALTH CARE; QUESTIONNAIRES; SCLERODERMA, SYSTEMIC; SOCIAL BEHAVIOR;

EID: 84860714257     PISSN: 0315162X     EISSN: 14992752     Source Type: Journal    
DOI: 10.3899/jrheum.110826     Document Type: Article

References (39)

1. Franck-Larsson K, Graf W, Ronnblom A. Lower gastrointestinal symptoms and quality of life in patients with systemic sclerosis: A population-based study. Eur J Gastroenterol Hepatol 2009;21:176-82.
2. Wegener M, Adamek RJ, Wedmann B, Jergas M, Altmeyer P. Gastrointestinal transit through esophagus, stomach, small and large intestine in patients with progressive systemic sclerosis. Dig Dis Sci 1994;39:2209-15. (Pubitemid 24341636)
3. Wielosz E, Borys O, Zychowska I, Majdan M. Gastrointestinal involvement in patients with systemic sclerosis. Pol Arch Med Wewn 2010;120:132-6.
4. Madsen JL, Hendel L. Gastrointestinal transit times of radiolabeled meal in progressive systemic sclerosis. Dig Dis Sci 1992;37:1404-8.
5. Battle WM, Snape WJ Jr, Wright S, Sullivan MA, Cohen S, Meyers A, et al. Abnormal colonic motility in progressive systemic sclerosis. Ann Intern Med 1981;94:749-52. (Pubitemid 11123367)
6. Whitehead WE, Taitelbaum G, Wigley FM, Schuster MM. Rectosigmoid motility and myoelectric activity in progressive systemic sclerosis. Gastroenterology 1989;96(2 Pt 1):428-32. (Pubitemid 19045274)
7. Harper RA, Jackson DC. Progressive systemic sclerosis. Br J Radiol 1965;38:825-34.
8. Martel W, Chang SF, Abell MR. Loss of colonic haustration in progressive systemic sclerosis. AJR Am J Roentgenol 1976;126:704-13.
9. Ferreiro JE, Busse JC, Saldana MJ. Megacolon in a collagen vascular overlap syndrome. Am J Med 1986;80:307-11. (Pubitemid 16140786)
10. Rohrmann CA Jr, Ricci MT, Krishnamurthy S, Schuffler MD. Radiologic and histologic differentiation of neuromuscular disorders of the gastrointestinal tract: Visceral myopathies, visceral neuropathies, and progressive systemic sclerosis. AJR Am J Roentgenol 1984;143:933-41. (Pubitemid 15207712)
11. Al-Dhaher FF, Pope JE, Ouimet JM. Determinants of morbidity and mortality of systemic sclerosis in Canada. Semin Arthritis Rheum 2010;39:269-77.
12. Hudson M, Thombs BD, Steele R, Panopalis P, Newton E, Baron M. Health-related quality of life in systemic sclerosis: A systematic review. Arthritis Rheum 2009;61:1112-20.
13. Talley NJ, Phillips SF, Wiltgen CM, Zinsmeister AR, Melton LJ 3rd. Assessment of functional gastrointestinal disease: The Bowel Disease Questionnaire. Mayo Clin Proc 1990;65:1456-79.
14. Guyatt G, Mitchell A, Irvine EJ, Singer J, Williams N, Goodacre R, et al. A new measure of health status for clinical trials in inflammatory bowel disease. Gastroenterology 1989;96:804-10. (Pubitemid 19057603)
15. Groll D, Vanner SJ, Depew WT, Da Costa LR, Simon JB, Groll A, et al. The IBS-36: A new quality of life measure for irritable bowel syndrome. Am J Gastroenterol 2002;97:962-71. (Pubitemid 34408255)
16. Steen VD, Medsger TA Jr. The value of the Health Assessment Questionnaire and special patient-generated scales to demonstrate change in systemic sclerosis patients over time. Arthritis Rheum 1997;40:1984-91. (Pubitemid 27494658)
17. Khanna D, Hays RD, Park GS, Braun-Moscovici Y, Mayes MD, McNearney TA, et al. Development of a preliminary scleroderma gastrointestinal tract 1.0 quality of life instrument. Arthritis Rheum 2007;57:1280-6. (Pubitemid 47585475)
18. Khanna D, Hays RD, Maranian P, Seibold JR, Impens A, Mayes MD, et al. Reliability and validity of the University of California, Los Angeles Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Arthritis Rheum 2009;61:1257-63.
19. Baron M, Hudson M, Steele R, Lo E. Validation of the UCLA Scleroderma Clinical Trial Gastrointestinal Tract Instrument version 2.0 for systemic sclerosis. J Rheumatol 2011;38:1925-30.
20. Bae S, Allanore Y, Coustet B, Maranian P, Khanna D. Development and validation of French version of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. Clin Exp Rheumatol 2011;29(2 Suppl 65):S15-21.
21. Medsger TA Jr, Silman AJ, Steen VD, Black CM, Akesson A, Bacon PA, et al. A disease severity scale for systemic sclerosis: Development and testing. J Rheumatol 1999;26:2159-67. (Pubitemid 29487010)
22. Preliminary criteria for the classification of systemic sclerosis (scleroderma). Subcommittee for scleroderma criteria of the American Rheumatism Association Diagnostic and Therapeutic Criteria Committee. Arthritis Rheum 1980;23:581-90.
23. Khanna D, Furst DE, Maranian P, Seibold JR, Impens A, Mayes MD, et al. Minimally important differences of the UCLA Scleroderma Clinical Trial Consortium Gastrointestinal Tract Instrument. J Rheumatol 2011;38:1920-4.
24. Clements PJ, Becvar R, Drosos AA, Ghattas L, Gabrielli A. Assessment of gastrointestinal involvement. Clin Exp Rheumatol 2003;21(3 Suppl 29):S15-8.
25. Ruangjutipopan S, Kasitanon N, Louthrenoo W, Sukitawut W, Wichainun R. Causes of death and poor survival prognostic factors in Thai patients with systemic sclerosis. J Med Assoc Thai 2002;85:1204-9. (Pubitemid 36255032)
26. Trezza M, Krogh K, Egekvist H, Bjerring P, Laurberg S. Bowel problems in patients with systemic sclerosis. Scand J Gastroenterol 1999;34:409-13. (Pubitemid 29232377)
27. Thoua NM, Bunce C, Brough G, Forbes A, Emmanuel AV, Denton CP. Assessment of gastrointestinal symptoms in patients with systemic sclerosis in a UK tertiary referral centre. Rheumatology 2010;49:1770-5.
28. Nietert PJ, Mitchell HC, Bolster MB, Curran MY, Tilley BC, Silver RM. Correlates of depression, including overall and gastrointestinal functional status, among patients with systemic sclerosis. J Rheumatol 2005;32:51-7. (Pubitemid 40092591)
29. Karamanolis G, Tack J. Promotility medications - Now and in the future. Dig Dis 2006;24:297-307. (Pubitemid 44114423)
30. Fynne L, Kruse A, Borre M, Sondergaard K, Krogh K. Percutaneous endoscopic gastrostomy in patients with systemic sclerosis. Scand J Rheumatol 2010;39:266-8.
31. Verne GN, Eaker EY, Hardy E, Sninsky CA. Effect of octreotide and erythromycin on idiopathic and scleroderma-associated intestinal pseudoobstruction. Dig Dis Sci 1995;40:1892-901.
32. Nikou GC, Toumpanakis C, Katsiari C, Charalambopoulos D, Sfikakis PP. Treatment of small intestinal disease in systemic sclerosis with octreotide: A prospective study in seven patients. J Clin Rheumatol 2007;13:119-23. (Pubitemid 46884197)
33. Lindsey I, Farmer CR, Cunningham IG. Subtotal colectomy and cecosigmoid anastomosis for colonic systemic sclerosis: Report of a case and review of the literature. Dis Colon Rectum 2003;46:1706-11. (Pubitemid 37532357)
34. Stafford-Brady FJ, Kahn HJ, Ross TM, Russell ML. Advanced scleroderma bowel: Complications and management. J Rheumatol 1988;15:869-74.
35. Brown M, Teubner A, Shaffer J, Herrick AL. Home parenteral nutrition - An effective and safe long-term therapy for systemic sclerosis-related intestinal failure. Rheumatology 2008;47:176-9. (Pubitemid 351168227)
36. Forbes A, Marie I. Gastrointestinal complications: The most frequent internal complications of systemic sclerosis. Rheumatology 2009;48 Suppl 3:iii36-9.
37. Thoua NM, Schizas A, Forbes A, Denton CP, Emmanuel AV. Internal anal sphincter atrophy in patients with systemic sclerosis. Rheumatology 2011;50:1596-602.
38. Kenefick NJ, Vaizey CJ, Nicholls RJ, Cohen R, Kamm MA. Sacral nerve stimulation for faecal incontinence due to systemic sclerosis. Gut 2002;51:881-3. (Pubitemid 35408613)
39. Kowal-Bielecka O, Landewe R, Avouac J, Chwiesko S, Miniati I, Czirjak L, et al. EULAR recommendations for the treatment of systemic sclerosis: A report from the EULAR Scleroderma Trials and Research group (EUSTAR). Ann Rheum Dis 2009;68:620-8.